[Federal Register Volume 61, Number 43 (Monday, March 4, 1996)] [Notices] [Pages 8303-8304] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 96-4945] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Application Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on December 19, 1995, MD Pharmaceutical, Inc., 3501 West Garry Avenue, Santa Ana, California 92704, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Methylphenidate (1724)...................... II Diphenoxylate (9170)........................ II ------------------------------------------------------------------------ The firm plans to manufacture the listed controlled substances to make finished dosage forms for distribution to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objects to the issuance of the above application. Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than May 3, 1996. [[Page 8304]] Dated: February 26, 1996. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 96-4945 Filed 3-1-96; 8:45 am] BILLING CODE 4410-09-M